Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects

BACKGROUND: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hamodi, Zaid, Ismail, Ikram S, Saif-Ali, Riyadh, Ahmed, Khaled A, Muniandy, Sekaran
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064636/
https://www.ncbi.nlm.nih.gov/pubmed/21414238
http://dx.doi.org/10.1186/1475-2840-10-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064636/
https://www.ncbi.nlm.nih.gov/pubmed/21414238
http://dx.doi.org/10.1186/1475-2840-10-23

Ejemplares similares